Expert Opinion on Emerging Drugs, volume 29, issue 4, pages 321-325
ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?
Jordan R. Hansford
1, 2, 3
,
Neevika Manoharan
4, 5, 6
,
G. Bouche
7
,
Vijay Ramaswamy
8, 9, 10
,
Nada Jabado
11
,
E. Bouffet
12
2
Paediatric Neuro-Oncology, Cancer Precision Medicine, South Australia Health and Medical Research Institute, Adelaide, SA, Australia
|
3
4
Kids Cancer Centre, Sydney Children’s Hospital, Randwick, NSW, Australia
|
7
The Anticancer Fund, Meise, Belgium
|
Publication type: Journal Article
Publication date: 2024-10-01
Journal:
Expert Opinion on Emerging Drugs
scimago Q1
wos Q2
SJR: 0.881
CiteScore: 5.9
Impact factor: 2.7
ISSN: 14728214, 17447623
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Profiles